ghk cu injection safety adverse effects Rejuvenation and Youth with GHK-Cu Peptide Treatment GHK-Cu Dosage: A Doctor's Guide

Dahlstrom and Olinger, 2014)

Pinealon oral vs injectable represents two distinct pharmacokinetic pathways: oral administration subjects the peptide to enzymatic degradation in the GI tract with variable absorption (bioavailability estimated at 515%), while subcutaneous injection delivers the peptide directly into interstitial tissue where absorption into capillaries occurs rapidly and predictably, with bioavailability approaching 8095%

Malpractice Exposure: Administering an unapproved Category 2 substance lacking human clinical trials severely compromises a physician's defense in a medical malpractice suit

Factors Contributing to Deficiency: Reduced Stomach Acid: Older adults often produce less stomach acid, which is necessary for separating B12 from food proteins